RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. VP Venture Partners
V

VP Venture Partners portfolio

VP Venture Partners has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $23.08M.
Latest deal: Hemotune · Mar 25, 2024.
About this page

Its most recent investment on record is Hemotune's $15.52M Series B+ round in March 2024, alongside Hemex, OCCIDENT, Zürcher Kantonal Bank and 2 others. That company is in Health and bio. It has co-invested with Zürcher Kantonal Bank, OCCIDENT and Hemex, most often Zürcher Kantonal Bank (2 rounds).

What VP Venture Partners invests in

How VP Venture Partners invests

StageDealsCapital in rounds
Series B+ 2 100%$23.08M
YearDealsCapital in rounds
2022 1 50%$7.56M
2024 1 50%$15.52M

VP Venture Partners portfolio companies

CompanyRound with VP Venture PartnersTotal raisedLatest raise
HHemotune
Health and bio
Series B+ · $15.52M$28.66MMar 25, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name VP Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists VP Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/vp-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.